Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer?
- PMID: 17549090
- DOI: 10.1038/ncponc0849
Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer?
Comment on
-
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.N Engl J Med. 2006 Dec 28;355(26):2733-43. doi: 10.1056/NEJMoa064320. N Engl J Med. 2006. PMID: 17192538 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources